Robert Figlin
Spielberg Family Chair in Hematology-Oncology · Cedars-Sinai Medical Center
Credentials: · · · · ·
History
Present
- 1979–1981
Medical Oncology
1972–1976
Research
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
New England Journal of Medicine · 2007 · Last of 14 authors · 4,727 citations
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
New England Journal of Medicine · 2007 · 2,970 citations
The Lancet · 2008 · 2,480 citations
124 papers
59 papers · 25 as a fellow
36 papers
- RM
35 papers
- BG
31 papers
- TH
31 papers
30 papers · 2 as a fellow
24 papers · 13 as a resident
Grants
- 2009–2014
Palliative Care for Quality of Life and Symptom Concerns in Lung Cancer
National Cancer Institute · P01
Project lead · $1.6M · Beckman Research Institute/City of Hope
- 1981–2012
National Cancer Institute · P30
Contact PI · $7.7M · Beckman Research Institute/City of Hope
- 1992–2009
City of Hope Clinical Oncology Career Research Development Program
National Cancer Institute · K12
Contact PI · $949.7K · Beckman Research Institute/City of Hope
- 1997–2004
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $883.2K · University of California Los Angeles
Clinical trials
- 2012–2018
Principal investigator · Terminated · Phase 3
Argos Therapeutics
- 2003–2006
Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Principal investigator · Completed · Phase 1
Jonsson Comprehensive Cancer Center
- 2005
Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Study chair · Unknown · Phase 2
Jonsson Comprehensive Cancer Center
- 2001–2004
RPI.4610 in Treating Patients With Metastatic Kidney Cancer
Study chair · Completed · Phase 2
Ribozyome